Trials / Completed
CompletedNCT01785862
Ibuprofen Lozenge in Acute Sore Throat Pain
Study of Efficacy and Safety of V0498 Versus Placebo in Acute Sore Throat Pain.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 427 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of repeated doses of a low dosage of oromucosal Ibuprofen form (lozenge) versus placebo in patients suffering from acute sore throat pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen 25 mg | Lozenge, Oromucosal administration |
| DRUG | Placebo | Lozenge matching V0498 lozenge, Oromucosal administration |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2013-02-07
- Last updated
- 2013-06-27
Locations
14 sites across 4 countries: France, Germany, Latvia, United Kingdom
Source: ClinicalTrials.gov record NCT01785862. Inclusion in this directory is not an endorsement.